Entering text into the input field will update the search result below

Dr. Reddy's pays $5M to settle DOJ case over alleged violations of child-resistant packaging regs

Dec. 19, 2017 7:19 AM ETDr. Reddy's Laboratories Limited (RDY) StockBy: Douglas W. House, SA News Editor
  • Dr. Reddy's Laboratories (NYSE:RDY) and the U.S. Department of Justice have reached a settlement in a civil case that started about six years ago over alleged violations of the Consumer Product Safety Act involving child-resistant packaging, specifically six products with child-resistant blister packs.
  • The company has agreed to pay a $5M to settle the matter although it says it firmly disagrees with the government's allegations. There have been no reports of a child gaining access to the medications as a result of the packaging and no instances of harm to a child related to the packaging.
  • The six products have not been distributed in the packaging in question since 2012.

Recommended For You

More Trending News

About RDY Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
RDY--
Dr. Reddy's Laboratories Limited